Test Price
3,000 AED✅ Home Collection Available
Support: +971 54 548 8731
WhatsApp: +971 54 548 8731
Abnormal Mineralization Panel (Genetic Test) in UAE | 3000 AED | 2026 DHA Guidelines
تحليل لوحة التمعدن غير الطبيعي (الفحص الجيني بتقنية التسلسل الجيني المتقدم) في الإمارات | 3000 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Patient Guarantee
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Sequencing & Bioinformatics Pipeline.
Premium Logistics: VIP Mobile Phlebotomy & ISO-Certified Cold-Chain Home Collection (8 AM - 11 PM).
Clinical Guidance: Complimentary Telephonic Post-Test Genetic Counseling & Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology Comparison
The Abnormal Mineralization Panel is a comprehensive Next-Generation Sequencing (NGS) assay that analyzes the complete coding regions of 58 critical genes associated with skeletal, dermatological, and immunological mineralization disorders. This advanced molecular diagnostic test definitively identifies pathogenic variants in genes such as ABCC6, ALPL, and COL1A1/2, providing clinicians with a precise etiological diagnosis that supersedes non-specific biochemical screening. بديل عن التشخيص التخميني، يوفر هذا التحليل الجيني اليقين الجزيئي (Yaqeen Juzay'i) لتوجيه خطط العلاج الشخصية.
| Feature | Our Test (ISO Certified) | Standard Biochemical Panel |
|---|---|---|
| Precision & Depth | Molecular Diagnostic resolution; identifies single nucleotide variants, indels, and CNVs in 58 target genes via LC-MS/MS-validated NGS. | Phenomenological measurement of calcium/phosphate; fluctuates with diet/hormones. |
| Methodology | Next Generation Sequencing (NGS) with Clinical-Grade Bioinformatics Pipeline. | Automated Colorimetric/Photometric Assay. |
| Turnaround Time | 3 to 4 Weeks (Comprehensive Reporting). | 1-2 Days (Non-specific screen). |
Physician Insight & Clinical Safety Protocol
"As a clinician, I initiate this panel when a patient presents with a complex constellation of symptoms—such as recurrent pathological fractures and ectopic calcifications—that defy a straightforward diagnosis. It is crucial to understand that while this NGS test is highly sensitive, its results must be rigorously correlated with the patient’s phenotype and family history. Do not discontinue any prescribed medication, including calcilytics or bisphosphonates, without consulting your managing physician."
— Dr. PRABHAKAR REDDY (DHA License: 61713011), Clinical Consultant.
⚠️ Safe Testing & Medical Exclusion Protocol
- Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This test does not measure response to therapy; it identifies genetic etiology.
- Exclusion Criteria (Home Collection): Patients who are hemodynamically unstable, have a known history of severe vasovagal syncope during venipuncture, or are in acute metabolic crisis require specimen collection within a monitored hospital facility, not home phlebotomy.
- Emergency Red Flags: If you experience sudden, severe bone pain, acute loss of neurological function, or tetany, proceed immediately to the nearest Emergency Department. This genetic test is a diagnostic tool, not an emergency intervention.
- Minors Compliance (CDS Law 2026): Testing of individuals under 18 years strictly requires the explicit consent of a legal guardian and a documented pre-test genetic counseling session per UAE Federal mandate.
Patient FAQ & Clinical Guidance
Q: How does this NGS genetic panel definitively diagnose abnormal mineralization disorders?
A definitive molecular diagnosis is achieved by identifying pathogenic variants within the 58 genes specifically governing calcium-phosphate homeostasis and extracellular matrix integrity. يقدم هذا التحليل تشخيصًا نهائيًا (Tashkhisan Niha'iyyan) من خلال الكشف عن الطفرات الجينية المسببة للمرض، متجاوزًا بذلك فحوصات الدم التقليدية غير المحددة.
Q: What are the mandatory pre-test steps for compliance with the 2024 UAE healthcare law?
Mandatory pre-test compliance includes a comprehensive clinical history review and a dedicated genetic counseling session to map your family pedigree as stipulated by Federal Decree-Law No. 41. جلسة الاستشارة الوراثية الإلزامية (Jalsat Al-Istisharah Al-Wirathiyah Al-Ilzamiyah) ترسم سجل العائلة الوراثي، وهو شرط أساسي بموجب القانون الاتحادي الإماراتي لضمان التفسير الدقيق.
Q: What action is required if my identifies a Variant of Uncertain Significance (VUS)?
A VUS finding necessitates a multi-disciplinary re-evaluation involving your referring dermatologist, nutritionist, or geneticist, and does not constitute a positive diagnosis. يتطلب المتغير غير المؤكد الأهمية السريرية (Mutaghayyir Ghayr Mu'akkad Al-Ahammiyah) إعادة تقييم من قبل فريق طبي متعدد التخصصات لضمان عدم الإفراط في العلاج.
جميع الحقوق محفوظة | UAE Data Privacy Law (Federal Decree-Law No. 45 of 2021) Compliant. Clinical processing is governed by Federal Decree-Law No. 41 of 2024 (Art. 87) on Genetic Testing. All genetic data is anonymized and processed strictly within the UAE per PDPL mandates.
ISO 9001:2015 Quality Management Certified (Cert: INT/EGQ/2509DA/3139). Facility License No: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians